Ardent Health revises 2025 Adjusted EBITDA down $97.7M after SEC discussions

Ardent Health, Inc.

2025 Adjusted EBITDA revised from $545.0M to $447.3M; Adjusted EBITDAR from $709.3M to $611.6M.
Removed $97.7M in adjustments for accounts receivable collectability estimate and New Mexico professional liability accrual (both Q3 2025).
No impact on GAAP financials, net income, or 2026 guidance; 2023/2024 metrics unchanged.
Revisions follow discussions with SEC Division of Corporation Finance to drop these non-GAAP adjustments.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.